This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Recro Pharma, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Charles Alexander Freyer
Introduction
Charles Alexander Freyer is an accomplished inventor based in Glenside, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of intranasal formulations. His work focuses on enhancing the delivery of medications through innovative methods.
Latest Patents
Freyer holds a patent for "Intranasal dexmedetomidine compositions and methods of use thereof." This invention provides intranasal formulations comprising dexmedetomidine, or a pharmaceutically acceptable salt thereof, along with various uses for these formulations. This advancement has the potential to improve patient care by offering a new method of drug delivery.
Career Highlights
Freyer is currently associated with Recro Pharma, Inc., a company dedicated to developing innovative pharmaceutical solutions. His role at Recro Pharma allows him to leverage his expertise in drug formulation and delivery systems, contributing to the company's mission of enhancing therapeutic options for patients.
Collaborations
Throughout his career, Freyer has collaborated with notable colleagues, including Geraldine A. Henwood and Randall J. Mack. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical research and development.
Conclusion
Charles Alexander Freyer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in intranasal drug delivery,
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile